X24 SERAFIT violet (7/0) 1x0,45 DSS-10 - Serag-Wiessner (6O05131S) - Delynov

What is the SERAFIT violet (7/0) suture?

SERAFIT violet (7/0) is a Class III medical device manufactured by Serag-Wiessner GmbH & Co. KG. It is a synthetic, absorbable, and braided multifilament surgical suture. Its structure is composed of a glycolic acid homopolymer, which provides great flexibility during handling. This 7/0 calibre thread is packaged in boxes of 24 units, with a thread length of 45cm. Its violet color ensures excellent visibility in the operative field. This device complies with European standards with CE1014 marking, guaranteeing its conformity for demanding surgical interventions.

What are the clinical indications for this 7/0 absorbable suture?

This 7/0 absorbable suture is specifically indicated for oral and implant surgery procedures requiring high precision. Its polyglycolic acid braided multifilament design allows for precise approximation of soft tissues. It is particularly suitable for closing delicate flaps and managing thin mucous membranes where minimal trauma is required. The manufacturer Serag-Wiessner specifies that this material can also be used for ligatures aimed at closing hollow organs. The choice of this 7/0 calibre is preferred by practitioners during micro-surgical interventions where the discretion of the material and knot precision are paramount.

What are the technical characteristics of the DSS-10 needle?

The DSS-10 needle equipping reference 6O05131S is a 3/8 circle needle with a length of 10mm. Technically, the DSS code designates an atraumatic reverse cutting triangular point. This geometry is specially designed to penetrate dense tissues or thin mucous membranes without causing unnecessary tearing. Its atraumatic design facilitates the passage of the 45cm thread through the tissues, thereby reducing local post-operative inflammation. The combination of the 7/0 calibre and this 10mm needle allows the surgeon to perform extremely precise sutures, essential for aesthetic and functional healing in the periodontal zone.

What are the contraindications for the use of SERAFIT?

According to data from the manufacturer Serag-Wiessner, SERAFIT must not be used in clinical situations where prolonged or long-term mechanical stability of the suture material is essential. Due to its absorbable nature, it loses its tensile properties over time. Furthermore, the use of this device is strictly contraindicated in patients with a known allergy to any of its components, notably glycolic acid or possible coatings such as calcium stearate with polycaprolactone. It is imperative for the practitioner to check the patient's allergic history before any implantation of this Class III material.

How does absorption occur and what are the precautions?

The absorption of SERAFIT occurs by hydrolysis in the tissues, transforming the polymer into glycolic acid which is then metabolized by the body. This process first results in a decrease in tensile strength: the breaking strength loses approximately 60% of its initial value after 14 days in vitro. Total mass loss, or complete absorption, is generally finished after approximately 90 days in vivo. Special precautions must be taken in patients with delayed healing or in tissues with low blood supply, as this may lead to suture extrusion or delayed absorption. In-depth knowledge of surgical techniques is required to adapt knot tension.

Who is the manufacturer and what standards are respected?

The SERAFIT suture is produced by Serag-Wiessner GmbH & Co. KG, a recognized manufacturer located in Naila, Germany. This medical device is certified Class III and bears the CE1014 marking, attesting to its compliance with European regulatory requirements for implantable medical devices. The manufacturing process follows strict protocols to ensure the sterility and performance of the braided multifilament. Each box of 24 sutures (reference 6O05131S) is delivered with detailed instructions for use that the practitioner must read carefully. Compliance with these standards guarantees the traceability and safety of the material during its use in dental surgery practices or hospital settings.

State of the art

Modern synthetic sutures - absorbable or non-absorbable - are central to wound healing in oral surgery. Recent advances focus on reducing post-operative infections.